editorial · 1998
Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial?
As with the administration of insulin for diabetes mellitus, the rationale for administering purified α1-antiprotease in severe α1-antitrypsin (α1AT) deficie...
19 citationsDOI: https://doi.org/10.1136/thx.53.12.1007Open accessPDF reported by metadataFull text reported by metadata